Healthy Adults
Conditions
Interventions
Consumption of food containing plant extracts
Consumption of food placebo
Sponsors
EAS Inc.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Healthy men in their 30s to 50s who are concerned about the decline in male function in recent years (2) Those with a BMI of less than 30kg/m2 (3) Men who are not currently engaging in sexual activity with the aim of becoming pregnant (4) Those who are not undergoing infertility treatment (5) Those who are not currently smoking (those who have been abstaining from smoking for more than one year) (6) Those who can provide written consent to participate in the study voluntarily
Exclusion criteria
Exclusion criteria: (1) Those currently taking medication for any kind of disease (2) Those taking the test food or health food products containing the active ingredient of the test food (3) Those with functional erectile dysfunction (4) Those with serious diseases of the sugar metabolism, lipid metabolism, liver function, kidney function, heart, circulatory system, respiratory system, endocrine system, immune system, or nervous system, or those with mental disorders. and those with a history of such conditions (5) Those who have been judged to have a problem with participating in the trial due to abnormalities in their clinical test values in their most recent health checkup, etc. (6) Those with a current illness or a history of a serious illness that required medication (7) Those who may develop an allergy in relation to the study (8) Those who are judged to be unsuitable as test subjects based on the results of the lifestyle questionnaire (9) Those who are participating in other clinical research at the start of this study (10) Those who are judged to be unsuitable for participation in the study by the principal investigator (or the person in charge of conducting the study)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of daily life, fatigue | — |
Secondary
| Measure | Time frame |
|---|---|
| Salivary testosterone | — |
Countries
Japan
Contacts
Public ContactShigenori Nibun
EAS Inc. Clinical Trial Session
Outcome results
None listed